2 Articles
2 Articles
All
Left
Center
Right


Rifaximin Lowers Hepatic Encephalopathy Risk in Cirrhosis
Rifaximin was both effective and well-tolerated in reducing the risk for hepatic encephalopathy in patients with cirrhosis, according to a meta-analysis.
·United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage